Case Study

Jiwa Bio-Pharm Holdings Limited has sold a majority stake to U-Home Group International Ltd.

U-Home Group International Litd. has acquired 72.19% of the issued share capital in Jiwa Bio-Pharm Holdings Limited, for a consideration of US$35.9 million.

The company trades in pharmaceutical and healthcare products, research and development of chemical and biological products, and investment and treasury functions.

U-Home Group International Ltd. is a company owned by Yuhua Enterprises Co Ltd.

Oaklins' team in Hong Kong acted as financial advisor to Jiwa Bio-Pharm Holdings Limited regarding this transaction.

Tombstone image for Jiwa Bio-Pharm Holdings Limited has sold a majority stake to U-Home Group International Ltd.

KEY DEAL CONTACTS

Richard Winter

China

Managing Partner

VIEW PROFILE